My watch list  


News Myelofibrosis

  • Genetic model identifies primary myelofibrosis outcomes

    A group of investigators from Mayo Clinic and multiple academic research centers in Italy have identified a genetic model for predicting outcomes in patients with primary myelofibrosis who are 70 years or younger and candidates for stem cell transplant to treat their disease. The group's findings we more

  • 'Chromosomal Chaos:' Complex array of mutations found in rare, aggressive leukemia

    Sezary syndrome (SS), an aggressive leukemia of mature T cells, is more complicated at a molecular level than ever suspected, according to investigators from the Perelman School of Medicine at the University of Pennsylvania. With a poor prognosis and limited options for targeted therapies, fighting more

  • Bristol-Myers Squibb enters agreement to acquire Promedior, Inc.

    Bristol-Myers Squibb Company and Promedior, Inc. announced that the companies have entered into an agreement that grants Bristol-Myers Squibb an exclusive right to acquire Promedior and gain worldwide rights to its lead asset PRM-151, a recombinant form of human pentraxin-2 protein in Phase 2 develo more

All news on myelofibrosis

Publications Myelofibrosis

All publications on myelofibrosis


Myelofibrosis Myelofibrosis with myeloid metaplasia, also known as agnogenic myeloid metaplasia, chronic idiopathic myelofibrosis, and primary myelofibrosis, was first described in 1879 and is currently classified as a myeloproliferative disease ... more


This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE